CB Dolloway Accepts Two-Year Suspension For Anti-Doping Violation

UFC fighter CB Dollaway is out of action for two years after accepting a suspension for violating the UFC Anti-Doping policy. USADA announced on Monday (per MMA Weekly) that Dolloway accepted the suspension after testing positive for anastrozole, growth hormone releasing peptide 2 (GHRP-2 or pralmorelin), a metabolite of GHRP-2, and GHRP-6 in an out-of-competition sample provided in December of 2018. He also tested positive for clomiphene in an out-of-competition sample collected on February 9th, 2019.

The failed tests were treated as a single and first violation because it was determined via investigation that the tests were both consistent with being ingested before the date he received his notification of his first positive test on January 11th. He will be eligible to fight again on December 13th, 2020.